hcc78 harboring slc34a2 ros1 Search Results


hcc78 harboring slc34a2-ros1  (Bioarray Inc)
90
Bioarray Inc hcc78 harboring slc34a2-ros1
Control charts for CNA and fusion/skipping variant types. ( a ) CCDC6-RET fusion, ( b ) EML4-ALK fusion, ( c ) <t>CD74-ROS1</t> fusion, ( d ) ERBB2/HER2 amplification, and ( e ) MYC amplification detected within the positive control over seven days of testing.
Hcc78 Harboring Slc34a2 Ros1, supplied by Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcc78 harboring slc34a2-ros1/product/Bioarray Inc
Average 90 stars, based on 1 article reviews
hcc78 harboring slc34a2-ros1 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Control charts for CNA and fusion/skipping variant types. ( a ) CCDC6-RET fusion, ( b ) EML4-ALK fusion, ( c ) CD74-ROS1 fusion, ( d ) ERBB2/HER2 amplification, and ( e ) MYC amplification detected within the positive control over seven days of testing.

Journal: Diagnostics

Article Title: Analytic and Clinical Validation of a Pan-Cancer NGS Liquid Biopsy Test for the Detection of Copy Number Amplifications, Fusions and Exon Skipping Variants

doi: 10.3390/diagnostics12030729

Figure Lengend Snippet: Control charts for CNA and fusion/skipping variant types. ( a ) CCDC6-RET fusion, ( b ) EML4-ALK fusion, ( c ) CD74-ROS1 fusion, ( d ) ERBB2/HER2 amplification, and ( e ) MYC amplification detected within the positive control over seven days of testing.

Article Snippet: HCC78 harboring SLC34A2-ROS1 (Cat #: CSC-C0569; Creative Bioarray, NY, USA), CRL-5935 harboring EML4-ALK (Cat #: NCI-H2228; ATCC, Manassas, VA, USA), KM12 (acquired from MD Anderson Cancer Center, Houston, TX, USA) harboring TPM3-NTRK1, and HTB-178 (Cat #: NCI-H596, ATCC) harboring MET exon 14 skipping were used for fusions and exon skipping.

Techniques: Variant Assay, Amplification, Positive Control

Analytic sensitivity for the fusion/skipping variant type.

Journal: Diagnostics

Article Title: Analytic and Clinical Validation of a Pan-Cancer NGS Liquid Biopsy Test for the Detection of Copy Number Amplifications, Fusions and Exon Skipping Variants

doi: 10.3390/diagnostics12030729

Figure Lengend Snippet: Analytic sensitivity for the fusion/skipping variant type.

Article Snippet: HCC78 harboring SLC34A2-ROS1 (Cat #: CSC-C0569; Creative Bioarray, NY, USA), CRL-5935 harboring EML4-ALK (Cat #: NCI-H2228; ATCC, Manassas, VA, USA), KM12 (acquired from MD Anderson Cancer Center, Houston, TX, USA) harboring TPM3-NTRK1, and HTB-178 (Cat #: NCI-H596, ATCC) harboring MET exon 14 skipping were used for fusions and exon skipping.

Techniques: Variant Assay